Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Mast Therapeutics Inc completes acquisition of Aires Pharmaceuticals, Inc


Thursday, 27 Feb 2014 02:18pm EST 

Mast Therapeutics Inc:Completed its acquisition of Aires Pharmaceuticals, Inc.Aires became a wholly-owned subsidiary of Mast Therapeutics in exchange for a total of 5.2 million shares of Mast common stock, representing about 5 pct of Mast's outstanding common stock.About 80 pct of the shares comprising the merger consideration are being held back for a period of six months to satisfy any indemnification obligations of the former Aires' stockholders under the merger agreement. 

Company Quote

0.5299
-0.0073 -1.36%
24 Oct 2014